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Abstract
When the body gets infected by a pathogen the immune system develops
pathogen-specific immunity. Induced immunity decays in time and years after
recovery the host might become susceptible again. Exposure to the pathogen in
the environment boosts the immune system thus prolonging the time in which
a recovered individual is immune. Such an interplay of within host processes
and population dynamics poses significant challenges in rigorous mathematical
modeling of immuno-epidemiology. We propose a new framework to model SIRS
dynamics, monitoring the immune status of individuals and including both wan-
ing immunity and immune system boosting. Our model is formulated as a system
of two ODEs coupled with a PDE. After showing existence and uniqueness of a
classical solution, we investigate the local and the global asymptotic stability of
the unique disease-free stationary solution. Under particular assumptions on the
general model, we can recover known examples such as large systems of ODEs
for SIRWS dynamics, as well as SIRS with constant delay. Moreover, a new
class of SIS models with delay can be obtained in this framework.
KEYWORDS: Immuno-epidemiology; Waning immunity; Immune status; Boost-
ing; Physiological structure; Reinfection; Delay equations; Global stability;
Abstract Cauchy problem
AMS Classification: 92D30; 35Q91; 47J35; 34K17
1 Introduction
Models of SIRS type are a traditional topic in mathematical epidemiology. Classi-
cal approaches present a population divided into susceptibles (S), infectives (I) and
recovered (R), and consider interactions and transitions among these compartments.
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Susceptibles are those hosts who either have not contracted the disease in the past
or have lost immunity against the disease-causing pathogen. When a susceptible host
gets in contact with an infective one, the pathogen can be transmitted from the in-
fective to the susceptible and with a certain probability, the susceptible host becomes
infective himself. After pathogen clearance the infective host recovers and becomes
immune for some time, afterwards he possibly becomes susceptible again.
From the in-host point of view, immunity to a pathogen is the result of either ac-
tive or passive immunization. The latter one is a transient protection and is due to
the transmission of antibodies from the mother to the fetus through the placenta,
thanks to which the newborn is immune for several months after birth [21]. Active
immunization is either induced by natural infection or can be achieved by vaccine
administration [29, 13].
Let us first consider the case of natural infection. A susceptible host, also called
naive host, has a very low level of specific immune cells for a pathogen (mostly a
virus or a bacterium, but possibly also a fungus). The first response to a pathogen
is nonspecific, as the innate immune system cannot recognize the physical structure
of the pathogen. The innate immune response slows down the initial growth of the
pathogen, while the adaptive (pathogen-specific) immune response is activated. Clonal
expansion of specific immune cells (mostly antibodies or CTL cells) and pathogen
clearance follow. The population of pathogen-specific immune cells is maintained for
long time at a level that is much higher than in a naive host. These are the so-called
memory cells and are activated in case of secondary infection (see Fig. 1). Memory
cells rapidly activate the immune response and the host mostly shows mild or no
symptoms [33, 2].
Each exposure to the pathogen might have a boosting effect on the population of
specific memory cells. Indeed, the immune system reacts to a new exposure as it did
during primary infection, thus yielding an increased level of memory cells [2]. Though
persisting for long time after pathogen clearance, the memory cell population slowly
decays, and in the long run the host might lose his pathogen-specific immunity. Wodarz
[33] writes that it “is unclear for how long hosts are protected against reinfection, and
this may vary from case to case.”
Vaccine-induced immunity works similarly to immunity induced by the natural in-
fection. Agents contained in vaccines resemble, in a weaker form, the disease-causing
pathogen and force a specific immune reaction without leading to the disease. If the
vaccine is successful, the host is immunized for some time. Vaccinees experience im-
mune system boosting and waning immunity, just as hosts recovered from natural
infection do. In general, however, disease-induced immunity induces a much longer
lasting protection than vaccine-induced immunity does [29]. Waning immunity might
be one of the factors which cause, also in highly developed regions, recurrent out-
breaks of infectious diseases such as measles, chickenpox and pertussis. On the other
side, immune system boosting due to contact with infectives prolongs the protection
duration.
In order to understand the role played by waning immunity and immune system
boosting in epidemic outbreaks, in the recent past several mathematical models were
proposed. Few of these models describe only in-host processes which occur during and
after the infection [33, 14, 10]. Many more models, formulated in terms of ordinary
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differential equations (ODEs), consider the problem only at population level, defining
compartments for individuals with different levels of immunity and introducing transi-
tions between these compartments [9, 15]. Possibly, also vaccinated hosts or newborns
with passive immunity are included, and waning of vaccine-induced or passive immu-
nity are observed [27, 25, 23]. In some cases, e. g. in the model by Heffernan and
Keeling [15], a discretization of the immune status leads to a very large system of
ODEs. Simplified versions were suggested by Glass and Grenfell [12], Arinaminpathy
et al. [3] who add the class W of hosts with waning immunity. W-hosts can receive
immune system boosting due to contact with infectives or move back to the suscepti-
ble compartment due to immunity loss. Lavine et al. [17] extend the SIRWS model in
[12], dividing each population into age-classes of length of 6 months each and further
classifying immune hosts (R) and hosts with waning immunity (W) by the level of
immunity.
To describe the sole waning immunity process, authors have chosen delay differ-
ential equations (DDEs) models with constant or distributed delay [16, 30, 6, 5, 34].
The delay represents the average duration of the disease-induced immunity. However,
neither a constant nor a distributed delay allows for the description of immune system
boosting.
Martcheva and Pilyugin [20] suggest an SIRS model in which infective and recov-
ered hosts are structured by their immune status. In infective hosts the immune status
increases over the course of infection, while in recovered hosts the immune status de-
cays at some nonconstant rate. When the immune status has reached a critical level,
recovered hosts transit from the immune to the susceptible compartment.
The goal of the present paper is to suggest a general framework for modeling waning
immunity and immune system boosting in the context of population dynamics. We
want to understand how the population dynamics, and in particular the number of
infectives, affects waning immunity and immune system boosting in a recovered host
and how, in turn, these two in-host processes influence the population dynamics. In
contrast to the models proposed in [15, 17], we shall maintain the number of equations
as low as possible. For the sake of simplicity we do not include vaccination in this
model.
We suggest a model in which the immune population is structured by the level
of immunity, z ∈ [zmin, zmax]. Individuals who recover at time t enter the immune
compartment (R) with maximal level of immunity zmax. The level of immunity tends
to decay in time and when it reaches the minimal value zmin, the host becomes sus-
ceptible again. Immune system boosting is included by the mean of the probability
p(z, z˜), z ≥ z˜, z, z˜ ∈ R, that an individual with immunity level z˜ moves to immunity
level z, when exposed to the pathogen. At the same time we choose the susceptible
and the infective populations to be non-structured. In this way we combine a PDE
for the immune population with two ODEs for susceptible and infective hosts. The
physiological structure in the immune population is the key innovation of the modeling
approach, as it allows to describe at once both waning immunity (as a natural process
which occurs as time elapses) and immune system boosting. There is hence no need
to include any compartment for hosts with waning immunity as it was done, e. g. in
[12, 3].
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The paper is organized as follows. In Sect. 2 we carefully derive the model equa-
tions for the SIRS dynamics. This system will be referred to as model (M1). ODEs
for susceptibles and infectives are easily introduced, whereas the PDE for the struc-
tured immune population is derived from balance laws. Though at a first glance the
resulting immune hosts equation might resemble a size-structured model, there is a
crucial difference. In size-structured models, indeed, transitions occur only in one
direction, i. e., individuals grow in size but never shrink. On the other hand, our
physiologically structured population is governed by a differential equation which in-
cludes transport (decay of immune status) and jumps (boosting to any higher immune
status), describing movements to opposite directions. This makes the model analysis
particularly challenging.
In Sect. 3 we consider fundamental properties of solutions for the model (M1).
Writing the system as an abstract Cauchy problem in the state-space X := R× R ×
L1 ([zmin, zmax];R)\{0, 0, 0}, we can guarantee existence of a unique classical solution.
The proof requires a quite long computation which is postponed to the appendix. Fur-
ther, using an appropriate comparison system, we show nonnegativity of solutions and
determine an invariant subset in X .
In Sect. 4 we consider stationary solutions. The proof of existence of stationary
solution requires connection with the theory of Volterra integral equations. We show
that there exists a unique disease free equilibrium (DFE) and investigate its local and
global stability. Investigation of endemic equilibria is considered in a following work.
Finally in Sect. 5 and Sect. 6 we show how to obtain from the general model (M1)
various systems of ODEs, such as those in [12, 3, 15, 17], and systems of equations
with constant delay, such as those in [30, 16]. Moreover we obtain as a special case a
new class of SIS systems with delay.
2 A new class of models
In this section we derive the model equations for the SIRS dynamics. We start with
the ODEs for susceptibles and infectives, which can be easily introduced, and continue
with a PDE for the structured immune population, which we obtain from a discrete
approach. The result is the general model (M1). We conclude the session with remarks
on the total immune population.
2.1 Susceptibles and infectives
Let S(t) and I(t) denote the total population of susceptibles, respectively infectives,
at time t. In contrast to previous models which include short-term passive immunity
[27, 22, 23], we assume that newborns are all susceptible to the disease. To make the
model closer to real world phenomena we suppose that newborns enter the susceptible
population at rate b(N), dependent on the total population size N . In general one
could choose the natural death rate d(N) to be a function of the total population, too.
However, for simplicity of computation, we consider the case of constant death rate
d(N) ≡ d > 0. The death rate d is assumed to be the same for all individuals, but
infectives might die due to the infection, too.
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Figure 1: Level of pathogen-specific immune cells with respect to the time. Generation
of memory cells takes a few weeks: Once primary infection occurred the adaptive
immune system produces a high number of specific immune cells (clonal expansion).
After pathogen clearance, specific immune cells (memory cells) are maintained for
years at a level that is much higher than in a naive host. Memory cells are activated
in case of secondary infection.
Assumption 1. Let b : [0,∞)→ [0, b+], N 7→ b(N), with 0 < b+ <∞, be a nonnega-
tive C1-function, with b(0) = 0.
To guarantee that there exists a nontrivial equilibrium N∗ > 0, such that b(N∗) = dN∗
(see Fig. 2), we require the following.
Assumption 2. There is an N∗ > 0 such that for N ∈ (0, N∗) we have that
b(N) > dN , whereas for N > N∗ we have dN > b(N). Further it holds that
b′(N∗) :=
d b(N)
dN
|N=N∗ < d.
When we include disease-induced death at rate dI > 0, an equilibrium satisfies
b(N) = dN + dII. (1)
Contact with infectives (at rate βI/N) induces susceptible hosts to become infective
themselves. Infected hosts recover at rate γ > 0, that is, 1/γ is the average infection
duration. Once recovered from the infection, individuals become immune, however
there is no guarantee for life-long protection. Immune hosts who experience immunity
loss become susceptible again.
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N*
dN
b(N)
N
Figure 2: Model Assumptions: Birth and death rate as functions of the total popula-
tion N . In absence of disease-induced death there exists an equilibrium N∗ such that
b(N∗) = dN∗.
The dynamics of S and I is described by the following equations:
S ′(t) = b(N(t))︸ ︷︷ ︸
birth
− β
S(t)I(t)
N(t)︸ ︷︷ ︸
infection
− dS(t)︸ ︷︷ ︸
death
+ Λ︸︷︷︸
immunity loss
,
I ′(t) = β
S(t)I(t)
N(t)︸ ︷︷ ︸
infection
− γI(t)︸ ︷︷ ︸
recovery
− dI(t)︸ ︷︷ ︸
natural
death
− dII(t)︸ ︷︷ ︸
disease-induced
death
.
The term Λ, which represents transitions from the immune compartment to the suscep-
tible one, will be specified below together with the dynamics of the immune population.
2.2 Immune hosts
Let r(t, z) denote the density of immune individuals at time t with immunity level
z ∈ [zmin, zmax], 0 ≤ zmin < zmax <∞. The total population of immune hosts is given
by
R(t) =
∫ zmax
zmin
r(t, z) dz.
The parameter z describes the immune status and can be related to the number of
specific immune cells of the host (cf. Sect. 1). The value zmax corresponds to maximal
immunity, whereas zmin corresponds to low level of immunity.
We assume that individuals who recover at time t enter the immune compartment
(R) with maximal level of immunity zmax. The level of immunity tends to decay in
time and when it reaches the minimal value zmin, the host becomes susceptible again.
However, contact with infectives, or equivalently, exposure to the pathogen, can boost
the immune system from z ∈ [zmin, zmax] to any higher immune status, see Fig. 2.2. It
is not straightforward to determine how this kind of immune system boosting works,
as no experimental data are available. Nevertheless, laboratory analysis on vaccines
tested on animals or humans suggest that the boosting efficacy might depend on
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several factors, among which the current immune status of the recovered host and the
amount of pathogen he receives [1, 19]. Possibly, exposure to the pathogen can restore
the maximal level of immunity, just as natural infection does (we shall consider this
special case in Sect. 3.1).
Let p(z, z˜), z ≥ z˜, z, z˜ ∈ R denote the probability that an individual with immunity
level z˜ moves to immunity level z, when exposed to the pathogen. Due to the definition
of p(z, z˜) we have p(z, z˜) ∈ [0, 1], z ≥ z˜ and p(z, z˜) = 0, for all z < z˜. As we effectively
consider only immunity levels in the interval [zmin, zmax], we set
p(z, z˜) = 0, for all z˜ ∈ (−∞, zmin) ∪ (zmax,∞).
Then we have∫ ∞
−∞
p(z, z˜) dz =
∫ zmax
z˜
p(z, z˜) dz = 1, for all z˜ ∈ [zmin, zmax].
Exposure to the pathogen might restore exactly the immunity level induced by the
disease (zmax). In order to capture this particular aspect of immune system boosting,
we write the probability p(z, z˜) as the combination of a continuous (p0) and atomic
measures (Dirac delta):
p(z, z˜) = cmax(z˜)δ(zmax − z˜) + c0(z˜)p0(z, z˜) + c1(z˜)δ(z − z˜),
where
cmax : [zmin, zmax]→ [0, 1], y 7→ cmax(y), is a continuously differentiable function and
describes the probability that, due to contact with infectives, a host with immu-
nity level y boosts to the maximal level of immunity zmax.
c0 : [zmin, zmax]→ [0, 1], y 7→ c0(y), is a continuously differentiable function and de-
scribes the probability that, due to contact with infectives, a host with immu-
nity level y boosts to any other level z ∈ (y, zmax), according to the continuous
probability p0(z, y).
c1(y) : [zmin, zmax]→ [0, 1], y 7→ c1(y) = 1− cmax(y)− c0(y), describes the probability
that getting in contact with infectives, the host with immunity level y does not
experience immune system boosting.
The immunity level decays in time at some rate g(z) which is the same for all immune
individuals with immunity level z, that is,
d
dt
z(t) = g(z).
Assumption 3. Let g : [zmin, zmax]→ (0, Kg], Kg <∞ be continuously differentiable.
The positivity of g(z) is given by the fact that, if g(z˜) = 0 for some value
z˜ ∈ [zmin, zmax], there would be no change of the immunity level at z˜, contradict-
ing the hypothesis of natural decay of immune status.
7
Immune system
is boosted Immunity loss
Memory cell 
population
 (slow decrease)
zmin
zmax
z*     z+z- zmaxzmin
Figure 3: Model assumptions for the immune population. (a) Natural infection induces
the maximal level of immunity zmax. The level of immunity decays in time and when
it reaches the minimal value zmin, the host becomes susceptible again. Exposure to
the pathogen has a boosting effect on the immune system. (b) Contact with infectives
can boost the immunity level z ∈ [zmin, zmax] to any higher value.
In absence of immune system boosting, an infected host who recovered at time t0
becomes again susceptible at time t0 + T , where
T =
∫ zmax
zmin
1
g(z)
dz.
The above equality becomes evident with an appropriate change of variables. Setting
u = z(s), we find du = z′(s) ds = g(z(s)) ds. For the integration boundaries we have
zmax = z(t0) and zmin = z(t0 + T ). It follows that∫ zmax
zmin
1
g(z)
dz =
∫ t0+T
t0
ds = T.
To obtain a correct physical formulation of the equation for r(t, z), we start from a dis-
crete approach, as it could be done for age-structured or size-structured models [31, 11].
The number of immune individuals in the immunity range [z−∆z, z], z ∈ [zmin, zmax],
is r(t, z)∆z.
We track how many individuals enter and exit a small immunity interval [z−∆z, z]
in a short time ∆t ≪ 1. Starting at a time t with r(t, z)∆z individuals, we want to
describe the number of individuals at time t+∆t. Recall that the immunity level tends
to decay, hence individuals enter the interval from z and exit from z−∆z (i. e., tran-
sition occurs the other way around than in age-structured or size-structured models).
As contact with infective individuals might boost the immune system, an immune host
with immunity level in [z−∆z, z] can move from this interval to any higher immunity
level. For the same reason, immune individuals with any lower immunity level can
“jump” to the interval [z − ∆z, z]. We assume that contacts between infectives and
immune hosts occur at the same rate, βI/N , as between infectives and susceptibles.
Given any z ∈ [zmin, zmax], denote by Gz the partition of the interval [zmin, z] into
small intervals of length ∆z. Observe Gz ⊂ Gzmax for all z ∈ [zmin, zmax].
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The total number of immune individuals with immunity level in [z − ∆z, z] at time
t +∆t is given by
r(t+∆t, z)∆z = r(t, z)∆z︸ ︷︷ ︸
at time t
+ r(t, z)g(z)∆t︸ ︷︷ ︸
incoming (waning)
− r(t, z −∆z)g(z −∆z)∆t︸ ︷︷ ︸
outgoing (waning)
− dr(t, z)∆z∆t︸ ︷︷ ︸
die out
− β
I(t)
N(t)
r(t, z)∆z∆t︸ ︷︷ ︸
outgoing (boosting)
+
∑
v∈Gz
β
I(t)
N(t)
p(z, v)∆z r(t, v)∆v∆t
︸ ︷︷ ︸
incoming (boosting)
.
Perform division by ∆z > 0,
r(t+∆t, z) = r(t, z) + r(t, z)g(z)
∆t
∆z
− r(t, z −∆z)g(z −∆z)
∆t
∆z
− dr(t, z)∆t
− β
I(t)
N(t)
r(t, z)∆t +
∑
v∈Gz
β
I(t)
N(t)
p(z, v) r(t, v)∆v∆t,
and compute the limit ∆z → 0 (observe that also ∆v → 0, as ∆z and ∆v are elements
of the same partition) to get
r(t+∆t, z)− r(t, z) = ∆t
∂
∂z
(
g(z)r(t, z)
)
− dr(t, z)∆t
− β
I(t)
N(t)
r(t, z)∆t + β
I(t)
N(t)
∆t
∫ z
zmin
p(z, v)r(t, v) dv.
Finally, we divide by ∆t and let ∆t → 0. From the discrete approach derivation it
becomes clear that the quantity Λ, initially introduced in the S equation at p. 6 to rep-
resent the hosts who experience immunity loss, is given by the number g(zmin)r(t, zmin)
of immune hosts who reach the minimal level of immunity.
Altogether for t ≥ 0 we have the system of equations
S ′(t) = b(N(t)) − β
S(t)I(t)
N(t)
− dS(t) + g(zmin)r(t, zmin)︸ ︷︷ ︸
=:Λ
,
I ′(t) = β
S(t)I(t)
N(t)
− (γ + d+ dI)I(t),
(2)
with initial values S(0) = S0 > 0, I(0) = I0 ≥ 0, coupled with a partial differential
equation for the immune population,
∂
∂t
r(t, z)−
∂
∂z
(g(z)r(t, z)) = −dr(t, z)+β
I(t)
N(t)
(∫ z
zmin
p(z, v)r(t, v) dv − r(t, z)
)
, (3)
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Symbol Description
S(t) number of susceptibles at time t
I(t) number of infective hosts at time t
R(t) number of immune individuals at time t
r(t, z) density of immune individuals with immunity level z at time t
N(t) total population (N(t) = S(t) + I(t) +R(t)) at time t
b(N) recruitment rate
d natural death rate
dI disease-induced death rate
β transmission rate
γ recovery rate
g(z) natural decay of immunity
p(z, z˜) probability that boosting raises immunity level z˜ to level z
zmax maximal level of immune status in immune hosts
zmin minimal level of immune status in immune hosts
ψ(z) initial distribution for r(t, z)
Table 1: Notation for model (M1). All quantities are nonnegative.
where z ∈ [zmin, zmax], with boundary condition
g(zmax)r(t, zmax) = γI(t) + β
I(t)
N(t)
∫ zmax
zmin
p(zmax, v)r(t, v) dv, (4)
and initial distribution r(0, z) = ψ(z), z ∈ [zmin, zmax].
At a first glance equation (3) might resemble a size-structured model, but there is
an important difference. In size-structured models transitions occur only in one di-
rection, i. e., individuals grow in size but never shrink. The PDE (3) for the immune
population is governed by a transport process (decay of immune status) and jumps
(boosting to any higher immune status). The model analysis results much more chal-
lenging than the one of classical size-structured models.
In the following we refer to the complete system (2) – (4) as to model (M1). An
overview on the model notation is provided in Table 1.
2.3 Total number of immune individuals
From the PDE (3) – (4) we obtain the total number R(t) of immune individuals at
time t ≥ 0. Integrating the left-hand side of (3) in [zmin, zmax], we find∫ zmax
zmin
∂
∂t
r(t, z) dz −
∫ zmax
zmin
∂
∂z
(g(z)r(t, z)) dz
=
∂
∂t
∫ zmax
zmin
r(t, z) dz − g(zmax)r(t, zmax) + g(zmin)r(t, zmin)
= R′(t)−
(
γI(t) + β
I(t)
N(t)
∫ zmax
zmin
p(zmax, v)r(t, v) dv
)
︸ ︷︷ ︸
=
(4)
g(zmax)r(t,zmax)
+g(zmin)r(t, zmin).
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Similarly, integrating the right-hand side of (3) we have
−
∫ zmax
zmin
dr(t, z) dz + β
I(t)
N(t)
[∫ zmax
zmin
(∫ z
zmin
p(z, v)r(t, v) dv − r(t, z)
)
dz
]
= −dR(t) + β
I(t)
N(t)
[∫ zmax
zmin
∫ z
zmin
p(z, v)r(t, v) dv dz −R(t)
]
.
Altogether:
R′(t) = γI(t)− dR(t)− g(zmin)r(t, zmin) + β
I(t)
N(t)
[∫ zmax
zmin
p(zmax, v)r(t, v) dv
+
∫ zmax
zmin
∫ z
zmin
p(z, v)r(t, v) dv dz −R(t)
]
.
(5)
When an immune host comes in contact with infectives, his immune system gets
boosted so that either the maximal level of immunity or any other higher (or equal)
level of immunity is restored. This means that the terms in the square bracket in (5)
cancel out and the total immune population at time t satisfies
R′(t) = γI(t)− g(zmin)r(t, zmin)− dR(t). (6)
In other words, inflow at time t into the immune class occurs by recovery of infected
hosts, while outflow is either due to death or to immunity loss. Observe that the
result (6) holds also in the special case of no boosting (c0(z) ≡ 0 and cmax(z) ≡ 0, ∈
[zmin, zmax]), and in the case in which boosting always restores the maximal level of
immunity (c0(z) ≡ 0 and cmax(z) ≡ 1, z ∈ [zmin, zmax]).
3 Existence, uniqueness and positivity
Consider model (M1), with given initial data S(0) = S0 ≥ 0, I(0) = I0 ≥ 0 and
ψ(z) ≥ 0 for all z ∈ [zmin, zmax]. Let Y := L
1 ([zmin, zmax];R) with its usual norm, and
let r˜ ∈ Y be defined by
r˜(t) : [zmin, zmax]→ R, z 7→ r(t, z), t ≥ 0.
For given values of I and N , we define the map F (I,N) : Y → Y, φ 7→ F (I,N)φ by
(
F (I,N)φ
)
(z) = β
I
N
[∫ z
zmin
φ(v)(π(v)(z)) dv − φ(z)
]
, (7)
with π(v)(z) = p(z, v) ∈ [0, 1], v ∈ [zmin, zmax]. In this notation the initial condition
for r is given by r˜(0)(z) = ψ(z), z ∈ [zmin, zmax].
The state space for model (M1) is X := R × R × Y \ {0, 0, 0} with the norm ‖·‖X
defined by
‖x‖X := |x1|+ |x2|+
∫ zmax
zmin
|x3(z)| dz, for all x = (x1, x2, x3) ∈ X.
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Observe that for well-posedness of the model (M1) the zero is not an element of X .
For all t ≥ 0, we define x(t) = (S(t), I(t), r˜(t)) ∈ X . Then the model (M1) can be
formulated as a perturbation of a linear abstract Cauchy problem,
d
dt
x(t) + Ax(t) = Q(x(t)), t > 0,
x(0) = (S0, I0, ψ),
(8)
where A and Q are respectively a linear and a nonlinear operator on X , defined by
A1(x1, x2, x3) := dx1 + g(zmin)x3(zmin),
A2(x1, x2, x3) := (γ + d+ dI)x2,
A3(x1, x2, x3) := dx3 +
∂
∂z
(g(z)x3(z)) ,
and
Q1(x1, x2, x3) := b(xˆ)− β
x1x2
xˆ
,
Q2(x1, x2, x3) := β
x1x2
xˆ
,
Q3(x1, x2, x3) := F
(x2,xˆ)x3,
with xˆ := x1 + x2 +
∫ zmax
zmin
x3(z) dz.
The next result guarantees the existence and uniqueness of a classical solution. We
remark that it is called mild solution of (8) the continuous solution x of the integral
equation
x(t) = T (t)u(0) +
∫ t
0
T (t− s)Q(x(s)) ds,
where {T (t)}t≥0 is the C0-semigroup on X generated by −A. On the other side, a
function x : [0, T ) → X is a classical solution of (8) on [0, T ) if x is continuous on
[0, T ), continuously differentiable on (0, T ), u(t) is in the domain D(A) of A for all
t ∈ (0, T ) and (8) is satisfied on [0, T ) (see [26]).
Theorem 3.1. Let S(0) = S0 ≥ 0, I(0) = I0 ≥ 0 and ψ(z) ≥ 0 for all z ∈ [zmin, zmax]
be given. Let d > 0, b : [0,∞) → [0, b+], 0 < b+ < ∞ satisfy Assumption 1 and
Assumption 2, and g : [zmin, zmax]→ (0, Kg), 0 < Kg <∞ satisfy Assumption 3. For
given values I and N , let F (I,N) be defined by (7).
Then there exists a unique solution x on [0,∞) of the abstract Cauchy problem (8),
with initial data x(0) = (S0, I0, ψ) ∈ X.
Proof. To have existence of a unique (classical) solution on [0,∞) we need to show:
(i) that −A is the generator of a C0-semigroup on X and (ii) that Q is continuously
differentiable in X (see [26, Chap. 6]).
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(i) The first hypothesis is easily verified as A corresponds to the linear homogeneous
part of the system and its domain is
D(A) =
{
x ∈ R× R× C1([zmin, zmax]) such that
A3(x) ∈ Y and g(zmax)x3(zmax) = γx2
}
⊂ X.
Similar linear operators arising from population dynamics were considered in [31, 7].
(ii) Continuous differentiability of Q can be shown in two steps. First, for all x, w ∈ X ,
we determine the existence of the operator DQ(x;w) defined by
DQ(x;w) := lim
h→0
Q(x+ hw)−Q(x)
h
.
Second, we show that the operator DQ(x; ·) is continuous in x, that is
lim ‖DQ(x; ·)−DQ(y; ·)‖OP = 0 for ‖x− y‖X → 0,
where ‖ · ‖OP is the operator norm. These two steps require the long computation
included in the Appendix.
Note that to have the existence of a classical solution one has to show continuous
differentiability of Q. To have existence and uniqueness of a mild solution, as well as
continuous dependence on the initial data, it is sufficient to prove Lipschitz continuity
of Q [see 26].
From now on, we shall assume that all hypotheses of Theorem 3.1 hold.
Next we show that, given nonnegative initial data, model (M1) preserves nonnega-
tivity. We proceed in two steps. First we introduce model (M2) in which boosting
restores the maximal immune status. The PDE in model (M2) has the same char-
acteristic curves as the PDE in model (M1), allowing us to use it as a comparison
system in the proof of nonnegativity. There are other reasons to consider model (M2)
separately. On the one side, the assumption of boosting restoring maximal immunity
has been used in previous models, e.g. in [3]. On the other side, in Sect. 6.2 we shall
use model (M2) to obtain a new SIRS system with delay.
3.1 Model (M2): Boosting restores the maximal level of im-
munity
Let us assume that whenever an immune host comes in contact with the pathogen, his
immune system is boosted in such a way that the maximal immunity level is restored.
This means that
cmax(z) ≡ 1, c0(z) ≡ 0, z ∈ [zmin, zmax],
or equivalently,
p(zmax, z) = 1 and p(z˜, z) = 0, for all z ∈ [zmin, zmax], z˜ < zmax.
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This assumption modifies the equation (3) and the boundary condition (4) in model
(M1) as follows
∂
∂t
r(t, z)−
∂
∂z
(g(z)r(t, z)) = −dr(t, z)− r(t, z)β
I(t)
N(t)
, (9)
g(zmax)r(t, zmax) = γI(t) + β
I(t)
N(t)
R(t). (10)
The equations for S and I in model (M1) remain unchanged. We shall refer to the
system (2), (9) – (10) as to model (M2).
Just for a moment, assume that for some t ≥ 0 the values I(t) and S(t) are known,
and recall N(t) = I(t) + S(t) +R(t). For all t ≥ 0 let us define
B(t) = γI(t) + β
I(t)
N(t)
R(t),
and
µ(t, z) = d− g′(z) + β
I(t)
N(t)
.
Definition 1 (cf. [8]). Let T > 0. A nonnegative function r(t, z), with r(t, ·) inte-
grable, is a solution of the problem (9) on [0, T )× [zmin, zmax] if the boundary condition
(10) and the initial condition r(0, z) = ψ(z), z ∈ [zmin, zmax] are satisfied and
Dr(t, z) = −µ(t, z)r(t, z), t ∈ [0, T ), z ∈ [zmin, zmax],
with
Dr(t, z) := lim
h→0
r(t+ h, ϕ(t+ h; t, z))− r(t, z)
h
,
where ϕ(t; t0, z0) is the solution of the differential equation z
′(t) = g(z(t)) with initial
value z(t0) = z0.
We introduce the characteristic curve ζ(t) = ϕ(t; 0, zmax) which identifies the cohort
of individuals who recovered (hence have maximal level of immunity) at time t = 0.
In this way we distinguish between those individuals who recovered before time t = 0
and are already immune at the initial time, and those who recovered later than t = 0.
Then the problem (9)–(10) can be solved along the characteristics [see, e.g 8, 31] and
we have the solution
r(t, z) =


B(t∗)
g(zmax)
exp
(
−
∫ t
t∗
µ(s, ϕ(s; t∗, zmax)) ds
)
, z ≥ ζ(t)
ψ(ϕ(0; t, z)) exp
(
−
∫ t
0
µ(s, ϕ(s; t, z)) ds
)
, z < ζ(t),
(11)
where the time t∗ is implicitly given by
ϕ(t; t∗, zmax) = z.
As the death rate d > 0 is bounded, we can extend the solution to all positive times
t > 0 [see also 8, Sec. 3.3]. It is obvious that the solution r(t, z) is nonnegative for all
t ≥ 0, z ∈ [zmin, zmax].
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3.2 Nonnegative solutions of model (M1)
Define the set
D = {(S, I, r˜) such that S ≥ 0, I ≥ 0, and r˜(z) ≥ 0, z ∈ [zmin, zmax]} ⊂ X.
Theorem 3.2. The cone D is positively invariant for the model (M1).
Proof. We start with the infective population. Let I(0) ≥ 0 be given. If I(t¯) = 0
for some t¯ > 0, we have I ′(t¯) = 0, hence the I component is always nonnegative.
Further we have that(
I(t)
N(t)
)′
=
I(t)
N(t)
(
βS(t)− (γ + d+ dI) +
1
N(t)
(b(N(t)) − dN(t)− dII(t)
)
.
It follows that, given positive initial values, the total population is larger than zero for
all t > 0.
The equation for S includes the term g(zmin)r(t, zmin), which is given by the solu-
tion r(t, z) of the PDE (3)–(4). Let S(0) ≥ 0 be given. Assume r(t, zmin) ≥ 0 for all
t ≥ 0, hence g(zmin)r(t, zmin) ≥ 0 (recall g(z) > 0 by Assumption 3). We see that
S = 0 implies
S ′(t) = b(N(t)) + g(zmin)r(t, zmin) ≥ 0.
Hence, if g(zmin)r(t, zmin) ≥ 0, also S does not leave the nonnegative cone.
To conclude the proof, we have to show that r(t, z) ≥ 0 for all t ≥ 0, z ∈ [zmin, zmax].
First we show that strictly positive initial data r(0, z) = ψ(z) > 0, z ∈ [zmin, zmax]
lead to a strictly positive solution for all t > 0, z ∈ [zmin, zmax]. Assuming the contrary,
there is a time t¯ > 0 such that
(i) I(t) > 0, S(t) ≥ 0, N(t) > 0, for all t ∈ [0, t¯];
(ii) for all t ∈ [0, t¯), z ∈ [zmin, zmax], r(t, z) > 0, whereas r(t¯, z¯) = 0, for some
z¯ ∈ [zmin, zmax).
In other words, t¯ is the first time at which for some value z¯ ∈ [zmin, zmax) the solution
r(t, z) of (3)–(4) is zero. Note that the PDE (3) in model (M1) and the PDE (9) have
the same characteristic curves. By assumptions (i)-(ii), along the characteristics we
have the estimate
∂
∂t
r(t, z)−
∂
∂z
(g(z)r(t, z)) = −
(
d+ β
I(t)
N(t)
)
r(t, z)
+ β
I(t)
N(t)
∫ z
zmin
p(z, u)r(t, u) du︸ ︷︷ ︸
≥0
≥ −
(
d+ β
I(t)
N(t)
)
r(t, z).
We can use the equations (9)–(10) as comparison system for (3)–(4) along characteris-
tics. From (11) it is evident that the solution r(t¯, z¯) of (9)–(10) is going to be zero if and
only if the characteristic curve associated to the point (t¯, z¯) has a starting value (either
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ψ(ϕ(0; t¯, z¯)) or I(t∗), t∗ < t¯) equal to zero, contradicting to (i)-(ii). We conclude that,
given strictly positive initial data ψ(z) > 0, the solution r of (3)–(4) is strictly positive.
To complete the proof, we extend the result to nonnegative initial data. Let ψ(z) ≥ 0.
We introduce a value ǫ > 0 and repeat the same argument as above for initial data
ψǫ(z) := ψ(z) + ǫ > 0. Finally we let ǫ → 0. From the continuous dependence on
initial data (cf. Theorem 3.1 and Pazy, 1983, Chap. 6), it follows that r(t, z) ≥ 0 for
ψ(z) ≥ 0.
4 The disease free equilibrium
For investigation of stationary solutions of model (M1) we set the time derivative equal
to zero and consider the problem
0 = b(N∗)− β
S∗I∗
N∗
− dS∗ + g(zmin)r¯(zmin), (12)
0 = β
S∗I∗
N∗
− (γ + d+ dI)I∗, (13)
d
dz
(g(z)r¯(z)) = dr¯(z)− β
I∗
N∗
∫ z
zmin
p(z, u)r¯(u) du+ r¯(z)β
I∗
N∗
, (14)
g(zmax)r¯(zmax) = γI∗ + β
I∗
N∗
∫ zmax
zmin
p(zmax, u)r¯(u) du, (15)
where the star denotes a fixed point and the bar a stationary distribution. A stationary
solution of model (M1) is a triple {S∗, I∗, r¯(·)} ∈ X which satisfies (12)–(15).
The total population N∗ = S∗+ I∗+
∫ zmax
zmin
r¯(u)du satisfies condition (1). From the
equation (13) we see that either I∗ = 0 or I∗ > 0 and β
S∗
N∗
= (γ+d+dI). In this paper
we shall consider only the disease-free equilibrium (DFE), that is, the case I∗ = 0. The
study of the endemic case (I∗ > 0) requires a long and nontrivial analysis, including
the theory of Volterra integral equations, which is beyond the scope of this manuscript.
Before presenting further results we introduce the basic reproduction number R0 of
model (M1),
R0 =
β
γ + d+ dI
,
which indicates the average number of secondary infections generated in a fully sus-
ceptible population by one infected host over the course of his infection. The basic
reproduction number is a reference parameter in mathematical epidemiology used to
understand if, and in which proportion, the disease will spread among the population.
Proposition 1 (Existence and uniqueness of DFE). There is exactly one disease free
equilibrium (DFE), namely (S∗, 0, r¯(·)) = (N
∗, 0, 0).
Proof. In the case I∗ = 0, from (14)–(15) we have
d
dz
r¯(z) =
1
g(z)
(d− g′(z)) r¯(z),
g(zmax)r¯(zmax) = 0,
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hence the trivial solution r¯(z) ≡ 0. Since r¯(zmin) = 0, from (12) it follows that
b(N∗)− dS∗ = 0. In particular we have R∗ =
∫ zmax
zmin
r¯(z) dz = 0 and S∗ = N∗. From
Assumption 2 and condition (1), we obtain N∗ = N
∗.
Theorem 4.1 (Local stability of DFE). If R0 < 1, the DFE is locally stable.
Proof. We prove the stability from first principle. Fix ε > 0. From the Assumptions
1 and 2 on b(N) and d, there exists an ω > 0 such that ω < ε/3 and b(N) − dN is
monotone decreasing on (N∗−ω,N∗+ω). Let us defineM := b(N∗−ω)−d(N∗−ω) > 0.
Choose δ > 0 such that
δ ≤ min
{
ε
3
,
ε
3
d
γ
,
M
dI
,
ω
3
}
.
Assume that the initial data are given such that |S(0) − N∗| < δ, I(0) < δ and
R(0) =
∫ zmax
zmin
r(0, z)dz < δ. Then we show that |S(t) − N∗| < ε, I(t) < ε and
R(t) = ||r(t, ·)|| < ε holds for all t ≥ 0.
Since I(t) ≤ I(0)e−qt < δe−qt, we have I(t) < ε
3
< ε. Further, from R′(t) <
γδ−dR(t), we easily find R(t) < max{δ, γδ
d
} and R(t) < ε
3
< ε is also guaranteed. Now
we consider the susceptible population. Note that S(t) ≤ N(t). Let νˆ(t) be the solution
of the comparison equation to (16), νˆ ′(t) = b(νˆ(t))−dνˆ(t). Then for given initial value
νˆ(0) ∈ (N∗−3δ, N∗+3δ), the solution νˆ(t) converges to N∗ monotonically. Hence, we
have that N(0) = S(0) + I(0) +R(0) < N∗ + 3δ implies S(t) < N∗ + 3δ < N∗ + ε for
all t > 0. It remains to show that S(t) ≥ N∗ − ε for t ≥ 0. From the assumptions on
b(N), there is a value N¯ ∈ (N∗ − ω,N∗) such that b(N¯)− dN¯ − δdI = 0. Recall that
N ′(t) > b(N(t))− dN(t)− dIδ.
Let ν˘(t) be the solution of the comparison equation ν˘ ′(t) = b(ν˘(t))− dν˘(t)− dIδ, with
ν˘(0) = N∗−ω. Since N(0) > N∗−3δ > N∗−ω, and ν˘(t) converges monotonically to N¯ ,
from N(t) > ν˘(t) we find that N(t) > N∗−ω. Observe that N(t) = S(t)+ I(t)+R(t)
guarantees that S(t) > N(t) − 2ε
3
, since I(t) < ε
3
and R(t) < ε
3
hold. In particular,
S(t) > N∗ − ω − 2ε
3
> N∗ − ε.
Therefore we can conclude the global asymptotic stability of the disease free equi-
librium in X .
Define the threshold quantity R˜0 :=
β
γ+d
, that coincides with the basic reproduction
number in case of non-lethal diseases.
Theorem 4.2 (Global stability of DFE). If R˜0 < 1, the DFE is globally asymptotically
stable.
Proof. First we show that the components I and R of (2) converge to zero for
t→∞. Let q := β
(
1
R0
− 1
)
> 0. Then from (2), for any solution I(t) > 0 we have
I ′(t) = βI(t)
(
S(t)
N(t)
−
1
R0
)
< −qI(t),
hence I(t) < I(0)e−qt for all t > 0. Further, from (6), we have the estimate
R′(t) < γI(0)e−qt − dR(t),
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which implies R(t)→ 0 as t→∞.
Next we prove that there is an η > 0 such that for any positive solution, N∞ :=
lim inf t→∞N(t) > η. Observe that the total population N = S + I + R satisfies the
equation
N ′(t) = b(N(t))− dN(t)− dII(t). (16)
Recall the Assumption 2 on b(N) and d. Fix a value ξ < 1 such that b′(0)ξ > d. Then
we can choose a small η > 0 such that b(N) > b′(0)ξN for N ∈ (0, η).
Now we show that N∞ ≥ η. Assume the contrary. Then, there are two possibilities:
(i) there is a t∗ such that N(t) < η for all t > t∗, or
(ii) there is a sequence tk →∞ as k →∞ such that N(tk) = η and N
′(tk) ≤ 0.
If (i) holds, then for t > t∗ we have from (16)
N ′(t) > (b′(0)ξ − d)N(t)− dII(0)e
−qt.
Consider the ODE
x′(t) = Ax(t)− Be−Ct, (17)
with A, B, C > 0, which has the solution
x(t) =
Be−Ct
A+ C
+ eAt
(
x(0)−
B
A + C
)
.
Then clearly x(t) → ∞ whenever
(
x(0)− B
A+C
)
> 0. We can use the equation (17)
as a comparison system to (16) for t > t∗ with x(0) = N(0), and A = (b
′(0)ξ − d) >
0, B = dII(0) > 0, C = q > 0. From R˜0 < 1 it follows that dI < dI + d + γ − β = q.
Then B
A+C
< B
C
= dI
q
I(0) < I(0) ≤ N(0), hence N(t) → ∞ and we have found a
contradiction to N(t) < η.
On the other side, if (ii) holds, then from I(tk) → 0 and b(η) − dη > 0, there is
a k∗ such that dII(tk) < b(η)− dη for k > k∗. But then
0 ≥ N ′(tk) = b(N(tk))− dN(tk)− dII(tk) > b(η)− dη − dII(tk) > 0,
which is a contradiction. We conclude that N∞ ≥ η. From the fluctuation lemma,
there is a sequence tk →∞ such that N(tk)→ N∞ and N
′(tk)→ 0. Now, considering
equation (16) with t = tk, and taking the limit for k →∞, we obtain
0 = b(N∞)− dN∞,
which has the only solutions N∞ = 0 and N∞ = N
∗. Clearly, only N∞ = N
∗ is
possible. By the same argument, the fluctuation lemma provides us with N∞ = N∗,
thus N(t) → N∗. Given that I(t) → 0 and R(t) → 0, we proved that S(t) → N∗.
Thus every positive solution converges to the DFE. Moreover, from Theorem 4.1,
R0 < R˜0 < 1 guarantees the local stability of the DFE, and the proof is complete.
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Proposition 2 (Instability of DFE). If R0 > 1 the DFE is unstable.
Proof. By straightforward computation, the linearization of the I-equation of
model (M1) about the DFE yields the simple equation
v′(t) = (β − γ − d− dI)v(t) = (γ + d+ dI)(R0 − 1)v(t),
where v(t) is the linear perturbation of I∗ = 0. It is now evident that if R0 > 1, the
DFE repels the I component thus it is unstable.
5 Connection with ODE models
In Sect. 1 we mentioned several previous works which suggest compartment mod-
els for waning immunity and immune system boosting in terms of ODE systems
[3, 17, 15, 12, 9]. Thanks to the well-known method of lines we can obtain such
ODE systems from our model (M1).
The method of lines, mostly used to solve parabolic PDEs, is a technique in which
all but one dimension are discretized [see, e. g. 28]. In our case, we shall discretize
the level of immunity (z) and obtain a system of ordinary differential equations in the
time variable.
Let us define a sequence {zj}j∈N, with hj := zj+1 − zj > 0, for all j ∈ N. To
keep the demonstration as simple as possible, we choose a grid with only few points,
z1 := zmin < zW < zF < zmax and assume that hj = 1 for all j. We define the following
three subclasses of the R population:
• RF (t) := r(t, zF ) immune hosts with high level of immunity at time t. As their
immunity level is quite high, these individuals do not experience immune system
boosting. Level of immunity decays at rate µ := g(zF ) > 0.
• RW (t) := r(t, zW ) immune hosts with intermediate level of immunity at time t.
These individuals can get immune system boosting and move to RF . Level of
immunity decays at rate ν := g(zW ) > 0.
• RC(t) := r(t, zmin) immune hosts with critically low level of immunity at time
t. With probability θ boosting moves RC individuals to RW (respectively, with
probability (1−θ) to RF ). Level of immunity decays at rate σ := g(zmin) > 0. If
they do not get immune system boosting, these hosts become susceptible again.
In the following we show how to proceed in absence of immune system boosting. When
immune system boosting is added, the approximation technique remains unchanged.
For practical reasons we write the equation for r(t, z) in model (M1) in the form
∂
∂t
r(t, z) =
∂
∂z
(
g(z)r(t, z)
)
− dr(t, z), (18)
with boundary condition Rzmax(t) := r(t, zmax) = γI(t)/g(zmax).
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Using forward approximation for the z-derivative in (18), we obtain, e. g. for RF (t),
RF
′(t) =
∂
∂t
r(t, zF )
=
∂
∂z
(
g(zF )r(t, zF )
)
− dr(t, zF )
≈
g(zmax)r(t, zmax)− g(zF )r(t, zF )
zmax − zF︸ ︷︷ ︸
=1
− dr(t, zF )
= g(zmax)Rzmax(t)− µRF (t)− dRF (t)
= γI(t)− (µ+ d)RF (t).
Analogously we find equations for RW and RC . Altogether we obtain a system in
which a linear chain of ODEs replaces the PDE for the immune class,
S ′(t) = b(N(t)) − β
S(t)I(t)
N(t)
− dS(t) + σRC(t),
I ′(t) = β
S(t)I(t)
N(t)
− (γ + d+ dI)I(t),
RF
′(t) = γI(t)− µRF (t)− dRF (t),
RW
′(t) = µRF (t)− νRW (t)− dRW (t),
RC
′(t) = νRW (t)− σRC(t)− dRC(t).
The linear chain of ODEs provides a rough approximation of the PDE in model (M1).
Indeed, with the method of lines we approximate the PDE dynamics considering
changes only at the grid points (zmin, zW , zF , zmax), whereas the dynamics remains
unchanged in the interval between one grid point and the next one. In other words, we
average out over the immunity level in one immunity interval [zj , zj+1] and consider as
representative point of the interval the lowest boundary zj. This is also the reason why
we do not have a differential equation for Rzmax(t), but simply a boundary condition
at this point.
Including immune system boosting
Now we use the same approximation scheme for the full model (M1), which includes
also immune system boosting to any higher immunity level. To this purpose it is
necessary to specify the boosting probability p(z, z˜) with z ∈ [zmin, zmax], which we
choose as follows
p(z, z˜) =


1 if z˜ = zW , and z = zF ,
θ if z˜ = zmin, and z = zW ,
1− θ if z˜ = zmin, and z = zF ,
0 otherwise.
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Figure 4: Diagram of model (19). After recovery, individuals enter the RF class
and are protected for a while. Due to contact with infectives, the immune system
of partially immune individuals (RW and RC) can be boosted to a higher level of
immunity. Natural decay of the immune status moves individuals from RF to RW ,
from RW to RC and finally from RC to S.
The integral term in model (M1) is discretized by the mean of a finite sum and the
resulting ODE system is
S ′(t) = b(N(t))− β
S(t)I(t)
N(t)
− dS(t) + σRC(t),
I ′(t) = β
S(t)I(t)
N(t)
− (γ + d+ dI)I(t),
RF
′(t) = γI(t)− µRF (t)− dRF (t) + β
I(t)
N(t)
(
(1− θ)RC(t) +RW (t)
)
,
RW
′(t) = µRF (t)− νRW (t)− dRW (t) + β
I(t)
N(t)
(
θRC(t)−RW (t)
)
,
RC
′(t) = νRW (t)− σRC(t)− dRC(t)− β
I(t)
N(t)
RC(t).
(19)
To obtain an ODE system from model (M2), that is, the special case in which boosting
always restores the maximal level of immunity, we include all hosts who get immune
system boosting in the boundary condition,
Rzmax(t) =
1
g(zmax)
(
γI(t) + β
I(t)
N(t)
(RW (t) +RC(t))
)
.
This correspond to setting θ = 0 in (19).
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6 Connection with DDE models
Delay models with constant delay can be obtained from special cases of model (M1)
defining the delay τ as the duration of immunity induced by the natural infection. We
show here how the classical SIRS model with delay, as well as a new SIS model with
delay arise from model (M1).
6.1 SIRS with constant delay
Consider the general model (M1) and neglect the boosting effects after recovery, that
is, set cmax(z) ≡ 0 ≡ c0(z) for all z ∈ [zmin, zmax]. This means that equations (3)–(4)
change into
∂
∂t
r(t, z)−
∂
∂z
(g(z)r(t, z)) = −dr(t, z)
g(zmax)r(t, zmax) = γI(t).
From our assumptions, the disease-induced immunity lasts for a fix time, τ > 0 years,
given by ∫ zmax
zmin
1
g(x)
dx = τ.
We can express the total immune population at time t as the number of individuals
who recovered in the time interval [t− τ, t],
R(t) = γ
∫ t
t−τ
I(y)e−d(t−y) dy = γ
∫ τ
0
I(t− x)e−dx dx.
Differentiation with respect to t yields
R′(t) = γI(t)− γI(t− τ)e−dτ − dR(t). (20)
On the other side, we have the relation (6). Comparison between (20) and (6) yields
g(zmin)r(t, zmin) = γI(t− τ)e
−dτ ,
which confirms the model assumptions, namely, τ time after recovery immune hosts
who did not die in the τ interval of time become susceptible again. In other words, if
an individual who recovers at time t1 survives up to time t1 + τ , he exits the R class
and enters S. In turn, we find a delay term in the equation for S too, and have a
classical SIRS model with constant delay
S ′(t) = b(N(t))− β
S(t)I(t)
N(t)
− dS(t) + γI(t− τ)e−dτ ,
I ′(t) = β
S(t)I(t)
N(t)
− (γ + d+ dI)I(t),
R′(t) = γI(t)− γI(t− τ)e−dτ − dR(t).
This model was studied by Taylor and Carr [30].
22
6.2 A new class of SIRS models with constant delay
Consider the special case (M2) in which boosting restores the maximal level of immu-
nity. As in the previous case, let τ > 0 be the duration of immunity induced by the
natural infection. With the definition of the characteristic curve ζ(t) = ϕ(t; 0, zmax)
(cf. Sect. 3.1), we have the relation
zmin = ϕ(t; t− τ, zmax).
Thus, solving along the characteristics, for t > τ we have
r(t, zmin) =
B(t− τ)
g(zmin)
exp
(
−
∫ t
t−τ
µ(u, ϕ(u; t− τ, zmax)) du
)
=
B(t− τ)
g(zmin)
exp
(
−
∫ t
t−τ
(
d+ β
I(u)
N(u)
)
du
)
=
I(t− τ)
g(zmin)
(
γ +
βR(t− τ)
N(t− τ)
)
exp
(
−dτ − β
∫ t
t−τ
I(u)
N(u)
du
)
.
Assume for simplicity that there is no disease-induced death (dI = 0) and that the
total population is constant N(t) ≡ 1. Then, R(t) = 1 − S(t) − I(t) and we end up
with the system
S ′(t) = d(1− S(t))− βI(t)S(t)
+ I(t− τ) (γ + β (1− S(t− τ)− I(t− τ))) exp
(
−dτ − β
∫ t
t−τ
I(u) du
)
,
I ′(t) = βI(t)S(t)− (γ + d)I(t).
Immunity loss occurs at time t either for hosts who recovered from infection at time
t− τ , or for host who, being immune, were exposed to the pathogen at time t− τ , and
in the interval of time [t− τ, t] did neither die nor come in contact with infectives. It
seems that such a SIS model with constant delay has not been presented in previous
literature.
7 Discussion
This paper provides a general framework for modeling waning immunity and immune
system boosting. The model (M1) combines the in-host perspective with the popula-
tion dynamics, while keeping the number of equations as low as possible. To the best
of our knowledge, only the model proposed by Martcheva and Pilyugin [20] achieved
a similar result. However Martcheva and Pilyugin [20] give a different interpretation
of immune system boosting (observed only during the infectious period).
Although, when first examined, the immune hosts equation (3) in model (M1) could
look like a size-structured model, we explained in Sect. 2 that this is not the case. Equa-
tion (3) describes a physiologically structured population whose dynamics includes a
transport process and jumps. Such kind of models are very rare in mathematical biol-
ogy, possibly because they are not easily derived or because their qualitative analysis
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turns out to be very challenging. A somehow similar example for the transmission of a
microparasite was suggested in [32]. Their model is given by two PDEs for uninfected
and infected hosts structured by the level of immunity. However, existence/uniqueness,
positivity of solutions, or stability analysis were not considered in [32]. In contrast,
we provided in Sect. 3 results on existence of a unique classical solution and on posi-
tive invariance, whereas in Sect. 4 we discussed the global behavior of solutions with
respect to the disease-free equilibrium.
We have shown that (M1) is a general framework which allows to recover previous
models from the literature, such as systems of ODEs (Sect. 5), as well as models with
constant delay (Sect. 6). Systems of ODEs presented, e. g. in [3, 17, 15] can be ob-
tained by discretizing the PDE for the immune population in model (M1) with the
help of the method of lines. This method, however, provides only a rough approxima-
tion of the structured population.
The system suggested in [9] includes a boosting term where a constant value ν > 0,
the boosting rate, is multiplied by the force of infection β. Our work includes the case
ν ≤ 1, nevertheless our results can be easily extended to the case of any positive ν.
Models with constant delay, such as those in [30, 16], are obtained from model
(M1) neglecting immune system boosting. The delay represents the duration of the
immunity after natural infection. Moreover we could show that there is a new and so
far not studied class of SIS models with constant delay which can be obtained from
model (M2), the special case in which boosting always restores the maximal level of
immunity. Both limit cases, no boosting or boosting always to the maximal level of
immunity, can be reduced to systems of equations with constant delays. The same
cannot be stated for the more general case in which boosting can restore any higher
immunity level. In this case, indeed, the obtained delay is of state-dependent type.
As the connection between model (M1) and system of equations with state-dependent
delay is nontrivial, we leave it as a future project.
Setting up our model we did not restrict ourselves to a particular pathogen. Our
goal is to provide a general framework for immune response, immune system boosting
and waning immunity in the context of population dynamics. Choosing appropriate
model coefficients, which can be deduced from experimental data, the system (M1)
can be adapted to model epidemic outbreaks, such as measles, chickenpox, rubella,
pertussis. In this context it is worth mentioning that, to date, not many data are
available about immune system boosting after natural infection. Recent experimental
data provide some information on the effects of vaccines on the antibody level, see
for example [19] for hepatitis B in mice or [1, 18] for measles, mumps, rubella and
influenza in humans.
We conclude with some remarks on vaccination. As we have mentioned in Sect. 1,
immunization is not only the result of natural infection, but also of vaccination and
transmission of maternal antibodies (passive-immunity). In a highly vaccinated pop-
ulation there are a lot of individuals with vaccine-induced immunity and few infection
cases, as well as more individuals with low level of immunity. In other words, if a high
portion of the population gets the vaccine, there are very few chances for exposure to
the pathogen and consequently for immune system boosting in protected individuals.
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This might be one aspect which causes recurrent outbreaks of, e. g. measles or per-
tussis in highly vaccinated populations.
In order to understand how in-host processes like waning immunity and immune
system boosting are related to the dynamics of the population, and to provide a correct
and whole-comprehensive mathematical formulation for these phenomena we chose not
to include vaccination in our model (M1). One natural extension of our work in the
future is to include vaccine-induced immunity in our framework. The resulting ap-
proach may provide a general setting which connects various models in the literature,
for example in [25, 12, 3, 4, 24].
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A Proof of Theorem 3.1
In the following we show the continuous differentiability of the map Q, which is nec-
essary to have existence and uniqueness of a classical solution of the abstract Cauchy
problem (8). Continuous differentiability of Q can be shown in two steps: (a) First we
determine the existence of the operator DQ(x;w), for all x, w ∈ X , defined by
DQ(x;w) := lim
h→0
Q(x+ hw)−Q(x)
h
.
(b) Second we show that the operator DQ(x; ·) is continuous in x, that is
lim ‖DQ(x; ·)−DQ(y; ·)‖OP = 0 for ‖x− y‖X → 0,
where ‖ · ‖OP is the operator norm.
For simplicity of notation we write
DQ1(x;w) := P1(x;w)− P2(x;w),
DQ2(x;w) := P2(x;w),
DQ3(x;w) := −P3(x;w) + P4(x;w),
where
P1(x;w) := lim
h→0
b(xˆ+ hwˆ)− b(xˆ)
h
,
P2(x;w) := lim
h→0
1
h
β
(
(x1 + hw1)(x2 + hw2)
xˆ+ hwˆ
−
x1x2
xˆ
)
,
P3(x;w) := lim
h→0
1
h
β
(
(x2 + hw2)(x3(z) + hw3(z))
xˆ+ hwˆ
−
x2x3(z)
xˆ
)
,
P4(x;w) := lim
h→0
1
h
β
(
(x2 + hw2)
∫ z
zmin
(x3(u) + hw3(u)) p(z, u) du
xˆ+ hwˆ
−
x2
∫ z
zmin
x3(u)p(z, u) du
xˆ
)
.
Proof of (a). We compute the limit for the first component of Q1,
P1(x;w) = lim
h→0
1
h
(
b (xˆ+ hwˆ)− b (xˆ+ hw1 + hw2)
)
+ lim
h→0
1
h
(
b (xˆ+ hw1 + hw2)− b (xˆ+ hw1)
)
+ lim
h→0
1
h
(
b (xˆ+ hw1)− b (xˆ)
)
= lim
h→0
b (xˆ+ hwˆ)− b (xˆ+ hw1 + hw2)
h
∫ zmax
zmin
w3(u) du
∫ zmax
zmin
w3(u) du
+ lim
h→0
b (xˆ+ hw1 + hw2)− b (xˆ+ hw1)
hw2
w2
+ lim
h→0
b (xˆ+ hw1)− b (xˆ)
hw1
w1
= b′(xˆ)wˆ.
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For the second term in Q1(x) we have
P2(x;w) = β lim
h→0
1
h
(
(x1 + hw1)(x2 + hw2)
xˆ+ hwˆ
−
(x1 + hw1)(x2 + hw2)
xˆ+ hw2 + h
∫ zmax
zmin
w3(u) du
)
+ β lim
h→0
1
h
(
(x1 + hw1)(x2 + hw2)
xˆ+ hw2 + h
∫ zmax
zmin
w3(u) du
−
x1(x2 + hw2)
xˆ+ hw2 + h
∫ zmax
zmin
w3(u) du
)
+ β lim
h→0
1
h
(
x1(x2 + hw2)
xˆ+ hw2 + h
∫ zmax
zmin
w3(u) du
−
x1(x2 + hw2)
xˆ+ h
∫ zmax
zmin
w3(u) du
)
+ β lim
h→0
1
h
(
x1(x2 + hw2)
xˆ+ h
∫ zmax
zmin
w3(u) du
−
x1x2
xˆ+ h
∫ zmax
zmin
w3(u) du
)
+ β lim
h→0
1
h
(
x1x2
xˆ+ h
∫ zmax
zmin
w3(u) du
−
x1x2
xˆ
)
= −β lim
h→0
(x1 + hw1)(x2 + hw2)
(xˆ+ hwˆ)
(
xˆ+ hw2 + h
∫ zmax
zmin
w3(u) du
) w1
+ β lim
h→0
x2 + hw2
xˆ+ hw2 + h
∫ zmax
zmin
w3(u) du
w1
− β lim
h→0
x1(x2 + hw2)(
xˆ+ hw2 + h
∫ zmax
zmin
w3(u) du
)(
xˆ+ h
∫ zmax
zmin
w3(u) du
) w2
+ β lim
h→0
x1
xˆ+ h
∫ zmax
zmin
w3(u) du
w2
− β lim
h→0
x1x2(
xˆ+ h
∫ zmax
zmin
w3(u) du
)
xˆ
∫ zmax
zmin
w3(u) du
= β
[
x2(xˆ− x1)
xˆ2
w1 +
x1(xˆ− x2)
xˆ2
w2 −
x1x2
xˆ2
∫ zmax
zmin
w3(u) du
]
.
The first term in Q3(x):
P3(x;w) = β lim
h→0
1
h
(
(x2 + hw2)(x3(z) + hw3(z))
xˆ+ hwˆ
−
(x2 + hw2)(x3(z) + hw3(z))
xˆ+ hw2 + h
∫ zmax
zmin
w3(u) du
)
+ β lim
h→0
1
h
(
(x2 + hw2)(x3(z) + hw3(z))
xˆ+ hw2 + h
∫ zmax
zmin
w3(u) du
−
x2(x3(z) + hw3(z))
xˆ+ hw2 + h
∫ zmax
zmin
w3(u) du
)
+ β lim
h→0
1
h
(
x2(x3(z) + hw3(z))
xˆ+ w2 + h
∫ zmax
zmin
w3(u) du
−
x2(x3(z) + hw3(z))
xˆ+ h
∫ zmax
zmin
w3(u) du
)
+ β lim
h→0
1
h
(
x2(x3(z) + hw3(z))
xˆ+ h
∫ zmax
zmin
w3(u) du
−
x2x3(z)
xˆ+ h
∫ zmax
zmin
w3(u) du
)
+ β lim
h→0
1
h
(
x2x3(z)
xˆ+ h
∫ zmax
zmin
w3(u) du
−
x2x3(z)
xˆ
)
.
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Hence we have
P3(x;w) = −β lim
h→0
(x2 + hw2)(x3(z) + hw3(z))
(xˆ+ hwˆ)
(
xˆ+ hw2 + h
∫ zmax
zmin
w3(u) du
) w1
+ β lim
h→0
x3(z) + hw3(z)
xˆ+ hw2 + h
∫ zmax
zmin
w3(u) du
w2
− β lim
h→0
x2(x3(z) + hw3(z))(
xˆ+ hw2 + h
∫ zmax
zmin
w3(u) du
)(
xˆ+ h
∫ zmax
zmin
w3(u) du
) w2
+ β lim
h→0
x2
xˆ+ h
∫ zmax
zmin
w3(u) du
w3(z)
− β lim
h→0
x2x3(z)
xˆ
(
xˆ+ h
∫ zmax
zmin
w3(u) du
) ∫ zmax
zmin
w3(u) du
= β
[
−
x2x3(z)
xˆ2
w1 +
x3(z)(xˆ− x2)
xˆ2
w2 +
x2
xˆ
w3(z)−
x2x3(z)
xˆ2
∫ zmax
zmin
w3(u) du
]
.
Analogously, compute the last term in Q3(x),
P4(x;w) = β lim
h→0
∫ z
zmin
(x3(u) + hw3(u)) p(z, u) du
xˆ+ hwˆ
w2
− β lim
h→0
x2
∫ z
zmin
(x3(u) + hw3(u)) p(z, u) du
(xˆ+ hwˆ)
(
xˆ+ hw2 + h
∫ zmax
zmin
w3(u) du
) w1
+ β lim
h→0
x2
xˆ+ hw2 + h
∫ zmax
zmin
w3(u) du
∫ z
zmin
w3(u) p(z, u) du
− β lim
h→0
x2
∫ z
zmin
x3(u) p(z, u) du(
xˆ+ hw2 + h
∫ zmax
zmin
w3(u) du
)(
xˆ+ h
∫ zmax
zmin
w3(u) du
) w2
− β lim
h→0
x2
∫ z
zmin
x3(u) p(z, u) du(
xˆ+ h
∫ zmax
zmin
w3(u) du
)
xˆ
∫ zmax
zmin
w3(u) du
= β
[
−
x2
∫ z
zmin
x3(u) p(z, u) du
xˆ2
w1 +
(xˆ− x2)
∫ z
zmin
x3(u) p(z, u) du
xˆ2
w2
+
x2
(
xˆ−
∫ z
zmin
x3(u) p(z, u) du
)
xˆ2
∫ zmax
zmin
w3(u) du

 .
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To prove that the operator DQ(x; ·) is continuous in x we consider the norm
‖DQ(x; ·)−DQ(y; ·)‖OP , that is
sup
‖w‖
X
≤1
‖DQ(x;w)−DQ(y;w)‖X
= sup
‖w‖
X
≤1
{
|P1(x;w)− P1(y;w)− P2(x;w) + P2(y;w)|+ |P2(x;w)− P2(y;w)|
+
∫ zmax
zmin
|(P3(y;w)− P3(x;w) + P4(x;w)− P4(y;w))(z)| dz
}
,
and show that
‖DQ(x; ·)−DQ(y; ·)‖OP → 0, for ‖x− y‖X → 0.
We estimate the operator norm as follows
sup
‖w‖
X
≤1
‖DQ(x;w)−DQ(y;w)‖X ≤ sup
‖w‖
X
≤1
4∑
j=1
Tj(x, y;w),
with
T1(x, y;w) = |P1(x;w)− P1(y;w)|,
T2(x, y;w) = 2|P2(x;w)− P2(y;w)|,
T3(x, y;w) =
∫ zmax
zmin
|(P3(x;w)− P3(y;w))(z)| dz,
T4(x, y;w) =
∫ zmax
zmin
|(P4(x;w)− P4(y;w))(z)| dz.
Then we show the convergence to zero of the above sum. It is obvious that
sup
‖w‖
X
≤1
T1(x, y;w) → 0, for ‖x− y‖X → 0,
as b is continuously differentiable (see Assumption 1),
|P1(x;w)− P1(y;w)| = |b
′(xˆ)wˆ − b′(yˆ)wˆ| ≤ |b′(xˆ)− b′(yˆ)| ‖w‖X .
The term in T2(x, y;w) can be estimated as follows:
|P2(x;w)− P2(y;w)| ≤ β
∣∣∣∣
(
x2(xˆ− x1)
xˆ2
−
y2(yˆ − y1)
yˆ2
)∣∣∣∣ |w1|︸ ︷︷ ︸
=:L1(x,y;w)
+ β
∣∣∣∣
(
x1(xˆ− x2)
xˆ2
−
y1(yˆ − y2)
yˆ2
)∣∣∣∣ |w2|︸ ︷︷ ︸
=:L2(x,y;w)
+ β
∣∣∣∣
(
x1x2
xˆ2
−
y1y2
yˆ2
)∣∣∣∣
∫ zmax
zmin
|w3(u)| du︸ ︷︷ ︸
=:L3(x,y;w)
.
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Since the addends of the last sum are all similar, we show convergence to zero for only
one of them.
sup
‖w‖
X
≤1
L3(x, y;w)
≤ β
∣∣∣∣x1x2xˆ2 − y1y2yˆ2
∣∣∣∣
≤ β
(∣∣∣∣x1x2xˆ2 − x1x2xˆyˆ
∣∣∣∣+
∣∣∣∣x1x2xˆyˆ − x1y2xˆyˆ
∣∣∣∣ +
∣∣∣∣x1y2xˆyˆ − x1y2yˆ2
∣∣∣∣ +
∣∣∣∣x1y2yˆ2 − y1y2yˆ2
∣∣∣∣
)
≤ β
(∣∣∣∣x1x2(yˆ − xˆ)xˆ2yˆ
∣∣∣∣ +
∣∣∣∣x1(x2 − y2)xˆyˆ
∣∣∣∣ +
∣∣∣∣x1y2(yˆ − xˆ)xˆyˆ2
∣∣∣∣+
∣∣∣∣(x1 − y1)y2yˆ2
∣∣∣∣
)
≤
3β
|yˆ|
‖x− y‖X .
It works analogously for the terms L1(x, y;w) and L2(x, y;w). Hence we have that
sup
‖w‖
X
≤1
T2(x, y;w) → 0, for ‖x− y‖X → 0.
In a similar way one can estimate T3(x, y;w) and T4(x, y;w). We show the computation
for T4 which is the most challenging of the two, as it includes double integrals.
T4(x, y;w) ≤ β
∫ zmax
zmin
∣∣∣∣∣x2
∫ z
zmin
x3(u) p(z, u) du
xˆ2
−
y2
∫ z
zmin
y3(u) p(z, u) du
yˆ2
∣∣∣∣∣ |w1| dz︸ ︷︷ ︸
=:F1(x,y;w)
+ β
∫ zmax
zmin
∣∣∣∣∣(xˆ− x2)
∫ z
zmin
x3(u) p(z, u) du
xˆ2
−
(yˆ − y2)
∫ z
zmin
y3(u) p(z, u) du
yˆ2
∣∣∣∣∣ |w2| dz︸ ︷︷ ︸
=:F2(x,y;w)
+ β
∫ zmax
zmin
∣∣∣∣x2xˆ − y2yˆ
∣∣∣∣
∫ zmax
zmin
|w3(u)| du dz︸ ︷︷ ︸
=:F3(x,y;w)
+ β
∫ zmax
zmin
∣∣∣∣∣x2
∫ z
zmin
x3(u) p(z, u) du
xˆ2
−
y2
∫ z
zmin
y3(u) p(z, u) du
yˆ2
∣∣∣∣∣
∫ zmax
zmin
|w3(u)| du dz︸ ︷︷ ︸
=:F4(x,y;w)
.
Before proceeding to the next estimate, it is useful to observe that∫ zmax
zmin
∫ z
zmin
x3(v)p(z, v) dv dz =
∫ zmax
zmin
∫ zmax
v
x3(v)p(z, v) dz dv
=
∫ zmax
zmin
x3(v)
∫ zmax
v
p(z, v) dz︸ ︷︷ ︸
=1
dv
=
∫ zmax
zmin
x3(v) dv.
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Let us now consider the last addend in T4(x, y;w). We have that
sup
‖w‖
X
≤1
F4(x, y;w) ≤ β
∫ zmax
zmin
∣∣∣∣∣x2
∫ z
zmin
x3(u) p(z, u) du
xˆ2
−
y2
∫ z
zmin
y3(u) p(z, u) du
yˆ2
∣∣∣∣∣ dz
≤ β
∫ zmax
zmin
∣∣∣∣∣x2
∫ z
zmin
x3(u) p(z, u) du
xˆ2
−
x2
∫ z
zmin
x3(u) p(z, u) du
xˆyˆ
∣∣∣∣∣ dz
+ β
∫ zmax
zmin
∣∣∣∣∣x2
∫ z
zmin
x3(u) p(z, u) du
xˆyˆ
−
x2
∫ z
zmin
y3(u) p(z, u) du
xˆyˆ
∣∣∣∣∣ dz
+ β
∫ zmax
zmin
∣∣∣∣∣x2
∫ z
zmin
y3(u) p(z, u) du
xˆyˆ
−
x2
∫ z
zmin
y3(u) p(z, u) du
yˆ2
∣∣∣∣∣ dz
+ β
∫ zmax
zmin
∣∣∣∣∣x2
∫ z
zmin
y3(u) p(z, u) du
yˆ2
−
y2
∫ z
zmin
y3(u) p(z, u) du
yˆ2
∣∣∣∣∣ dz.
A similar computation as the one for sup
‖w‖
X
≤1
L3(x, y;w) yields
sup
‖w‖
X
≤1
F4(x, y;w) ≤ β
∫ zmax
zmin
∫ z
zmin
|x3(u) p(z, u)| du dz
∣∣∣∣x2(yˆ − xˆ)xˆ2yˆ
∣∣∣∣
+ β
∫ zmax
zmin
∫ z
zmin
|x3(u) p(z, u)| du dz
∣∣∣∣x2(yˆ − xˆ)xˆyˆ2
∣∣∣∣
+ β
∫ zmax
zmin
∫ z
zmin
|(x3(u)− y3(u)) p(z, u)| du dz
∣∣∣∣x2xˆyˆ
∣∣∣∣
+ β
∫ zmax
zmin
∫ z
zmin
|y3(u) p(z, u)| du dz
∣∣∣∣x2 − y2yˆ2
∣∣∣∣
≤
3β
|yˆ|
‖x− y‖X .
Similar relations hold for the other terms F1(x, y;w), F2(x, y;w) and F3(x, y;w). It
is then obvious that the norm ‖DQ(x; ·) − DQ(y; ·)‖OP tends to zero, for ‖x− y‖X
going to zero, and the proof is complete.
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